Literature DB >> 22731720

Analysis of absorption enhancers in epithelial cell models.

Rita Rosenthal1, Miriam S Heydt, Maren Amasheh, Christoph Stein, Michael Fromm, Salah Amasheh.   

Abstract

A variety of chemical compounds are currently being discussed as novel drug delivery strategies. One promising strategy is to selectively open the paracellular pathway of epithelia for the passage of macromolecules. A prerequisite for this effect is a rapid and reversible action of these compounds, to allow a marked translocation of a drug, but also to avoid unwanted adverse effects, such as the translocation of noxious agents. Bioactive molecules that elevate paracellular permeability include Ca(2+) chelators, bacterial toxins, and other compounds, some of which perturb the structural basis of epithelial barrier function--the tight junction. Within the tight junction, organ- and tissue-specific barrier properties are determined mainly by claudins. The majority of members of the claudin protein family seal the paracellular pathway. This paper focuses on recent approaches concerning absorption-enhancing effects, with regard to selectivity and mechanism.
© 2012 New York Academy of Sciences.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22731720     DOI: 10.1111/j.1749-6632.2012.06562.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


  10 in total

1.  A role for tricellulin in the regulation of gill epithelium permeability.

Authors:  Dennis Kolosov; Scott P Kelly
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2013-04-17       Impact factor: 3.619

2.  Laurate permeabilizes the paracellular pathway for small molecules in the intestinal epithelial cell model HT-29/B6 via opening the tight junctions by reversible relocation of claudin-5. [Corrected].

Authors:  Isabel Dittmann; Maren Amasheh; Susanne M Krug; Alexander G Markov; Michael Fromm; Salah Amasheh
Journal:  Pharm Res       Date:  2014-03-15       Impact factor: 4.200

Review 3.  The role of epithelial tight junctions involved in pathogen infections.

Authors:  Ru-Yi Lu; Wan-Xi Yang; Yan-Jun Hu
Journal:  Mol Biol Rep       Date:  2014-06-26       Impact factor: 2.316

4.  Barrier Perturbation in Porcine Peyer's Patches by Tumor Necrosis Factor is Associated With a Dysregulation of Claudins.

Authors:  Linda Droessler; Valeria Cornelius; Elisa Boehm; Laura Stein; Nora Brunner; Salah Amasheh
Journal:  Front Physiol       Date:  2022-05-30       Impact factor: 4.755

5.  Comparative analysis of theophylline and cholera toxin in rat colon reveals an induction of sealing tight junction proteins.

Authors:  Alexander G Markov; Evgeny L Falchuk; Natalia M Kruglova; Oksana V Rybalchenko; Michael Fromm; Salah Amasheh
Journal:  Pflugers Arch       Date:  2014-02-11       Impact factor: 3.657

6.  Mechanisms allowing protein delivery in nasal mucosa using NPL nanoparticles.

Authors:  B Bernocchi; R Carpentier; I Lantier; C Ducournau; I Dimier-Poisson; D Betbeder
Journal:  J Control Release       Date:  2016-04-11       Impact factor: 9.776

7.  Human claudin-8 and -14 are receptors capable of conveying the cytotoxic effects of Clostridium perfringens enterotoxin.

Authors:  Archana Shrestha; Bruce A McClane
Journal:  MBio       Date:  2013-01-15       Impact factor: 7.867

8.  A novel perspective and approach to intestinal octreotide absorption: sinomenine-mediated reversible tight junction opening and its molecular mechanism.

Authors:  Yuling Li; Zhijun Duan; Yan Tian; Zhen Liu; Qiuming Wang
Journal:  Int J Mol Sci       Date:  2013-06-20       Impact factor: 5.923

Review 9.  Tight junction physiology of pleural mesothelium.

Authors:  Alexander G Markov; Salah Amasheh
Journal:  Front Physiol       Date:  2014-06-24       Impact factor: 4.566

10.  Aeromonas sobria Serine Protease Degrades Several Protein Components of Tight Junctions and Assists Bacterial Translocation Across the T84 Monolayer.

Authors:  Mitsunobu Ueda; Hidetomo Kobayashi; Soshi Seike; Eizo Takahashi; Keinosuke Okamoto; Hiroyasu Yamanaka
Journal:  Front Cell Infect Microbiol       Date:  2022-02-22       Impact factor: 5.293

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.